News Daily News Women With Early Menopause See Higher Heart Failure, AF Risks Yael L. Maxwell August 04, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for July 2022 Todd Neale August 01, 2022
News Daily News Knowns, Unknowns of Vaccine Myocarditis Risks Summarized in ‘Living’ Review Shelley Wood July 21, 2022
News Daily News Myocarditis Phenotype Is a Key Predictor of Outcomes in COVID-19 Michael O'Riordan July 20, 2022
News Daily News Black and Hispanic Patients Not Accessing High-Volume TEER Centers Michael O'Riordan July 19, 2022
News Daily News US Dobutamine Shortage a ‘Huge Problem’—What’s the Solution? Shelley Wood July 15, 2022
News Daily News Shock in Peripartum Cardiomyopathy Especially Risky in Black, Hispanic Patients Caitlin E. Cox July 13, 2022
News Daily News Quadruple Therapy Costs Prohibitive for Many HFrEF Patients L.A. McKeown June 21, 2022
News Daily News COVID-19 Had Broad Global Effects on CV Care, Review Affirms Todd Neale June 02, 2022
News Conference News ESC Heart Failure 2022 Patch-Pump Delivery of Subcutaneous Furosemide Opens Options in HF Shelley Wood May 26, 2022
News Daily News The Hunt for Protein Culprits in COVID-19’s Cardiac Complications Michael O'Riordan May 06, 2022
News Conference News HRS 2022 Evidence Grows for Conduction-System Pacing as an Alternative to CRT Todd Neale May 05, 2022
News Daily News Frailty Does Not Hinder Dapagliflozin’s HFrEF Impact: DAPA-HF Analysis Caitlin E. Cox May 03, 2022
News Daily News FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy Michael O'Riordan April 29, 2022
News Conference News ACC 2022 QoL Gains Within 15 Days in Acute HF With Empagliflozin: EMPULSE Analysis L.A. McKeown April 07, 2022
News Conference News ACC 2022 Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term Shelley Wood April 03, 2022
News Conference News ACC 2022 SODIUM-HF: No Impact of Tighter Dietary Salt Restriction on Death or Hospitalization L.A. McKeown April 02, 2022
News Conference News ACC 2022 New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More Shelley Wood April 01, 2022
News Daily News A ‘Call to Action’ for HF Trials: More Black, Hispanic Patients Caitlin E. Cox March 31, 2022